*Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A.;
†Division of Pediatric Pulmonology and Sleep Medicine, Department of Pediatrics, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.;
‡Department Sports and Health, Institute of Sports Medicine, Paderborn University, Paderborn, Germany; and
§Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, U.S.A.
Address correspondence and reprint requests to Tobias Loddenkemper, MD, Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, U.S.A.; e-mail: [email protected].
Investigator initiated grant (#IIR-USA-000062) from Mallinckrodt Pharmaceuticals (PI: T.L.). T. Loddenkemper and A. Tanritanir are part of a pending patent application related to EEG biomarkers in the setting of infantile spasms assessment. The remaining authors have no conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.clinicalneurophys.com).
